Current status and future prospects for anti-angiogenic therapies in cancer

Author： Staton Carolyn A   Brown Nicola J   Reed Malcolm WR  

Publisher： Informa Healthcare

ISSN： 1746-0441

Source： Expert Opinion on Drug Discovery, Vol.4, Iss.9, 2009-09, pp. : 961-979

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anti-Angiogenic Therapies for Children with Cancer

By  

Current Cancer Drug Targets, Vol. 10, Iss. 8, 2010-12 ,pp. : 879-889

Bentham Science Publishers

Access to resources Recommend Favorite

Do anti-angiogenic cancer therapies increase risk of significant weight loss?

By Zhang Shuang   Yu Min   Wei Yuquan  

Expert Opinion on Drug Safety, Vol. 13, Iss. 4, 2014-04 ,pp. : 473-482

Informa Healthcare

Access to resources Recommend Favorite

Novel Drug Delivery Systems for Sustained and Targeted Delivery of Anti-Cancer Drugs: Current Status and Future Prospects

By  

Current Drug Delivery, Vol. 7, Iss. 2, 2010-04 ,pp. : 152-161

Bentham Science Publishers

Access to resources Recommend Favorite

Antiangiogenic Therapy for Metastatic Breast Cancer: Current Status and Future Directions

By Chan Arlene  

Drugs, Vol. 69, Iss. 2, 2009-01 ,pp. : 167-181

Adis International

Access to resources Recommend Favorite

Novel Non-Cytotoxic Therapy in Ovarian Cancer: Current Status and Future Prospects

By Martin Lainie   Schilder Russell J.  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 4, Iss. 9, 2006-10 ,pp. : 955-966

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite